Published in World J Gastroenterol on October 01, 2001
Clinical usefulness of measuring red blood cell distribution width in patients with hepatitis B. PLoS One (2012) 1.19
Possible causes of central pontine myelinolysis after liver transplantation. World J Gastroenterol (2004) 0.97
Liver biopsy in evaluation of complications following liver transplantation. World J Gastroenterol (2004) 0.92
DNA-PKcs subunits in radiosensitization by hyperthermia on hepatocellular carcinoma hepG2 cell line. World J Gastroenterol (2002) 0.89
Incidence and treatment of hepatic artery complications after orthotopic liver transplantation. World J Gastroenterol (2003) 0.84
Combined small bowel and reduced auxiliary liver transplantation: case report. World J Gastroenterol (2002) 0.82
Liver retransplantation in adults: a single-centre, 25-year experience. HPB (Oxford) (2010) 0.80
Influence of intrauterine injection of rat fetal hepatocytes on rejection of rat liver transplantation. World J Gastroenterol (2003) 0.80
Influence of liver nonparenchymal cell infusion combined with cyclosporin A on rejection of rat small bowel transplantation. World J Gastroenterol (2003) 0.78
Establishment of a new pig model for auxiliary partial orthotopic liver transplantation. World J Gastroenterol (2005) 0.75
Modifications in combined liver-small bowel transplantation in pigs. World J Gastroenterol (2003) 0.75
Formation of microchimerism in rat small bowel transplantation by splenocyte infusion. World J Gastroenterol (2006) 0.75
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell (1991) 15.76
FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70
Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11
Early indicators of prognosis in fulminant hepatic failure. Gastroenterology (1989) 7.43
Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04
Increase in primary liver cancer in the UK, 1979-94. Lancet (1997) 6.15
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Organ donation from intensive care units in England and Wales: two year confidential audit of deaths in intensive care. BMJ (1992) 5.27
Detection of a novel DNA virus (TTV) in blood donors and blood products. Lancet (1998) 5.15
A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. The U.S. Multicenter FK506 Liver Study Group. N Engl J Med (1994) 4.22
Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg (1993) 3.91
Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group. Lancet (1994) 3.72
Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report. Transplant Proc (1988) 2.87
Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg (1990) 2.37
Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient. Gut (2000) 2.16
Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group. Lancet (2000) 1.95
Surgical techniques and innovations in living related liver transplantation. Ann Surg (1993) 1.88
Technical refinement in adult-to-adult living donor liver transplantation using right lobe graft. Ann Surg (2000) 1.86
Reduced-size orthotopic liver transplantation: use in the management of children with chronic liver disease. Hepatology (1989) 1.84
Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation (2000) 1.79
Living related liver transplantation in adults. Ann Surg (1998) 1.72
The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation. J Am Coll Surg (1996) 1.71
Piggy-back versus conventional technique in liver transplantation: report of a randomized trial. Transpl Int (1997) 1.70
The prophylactic effect of aprotinin on intraoperative bleeding in liver transplantation: a randomized clinical study. Hepatology (1997) 1.62
Hepatic artery thrombosis after liver transplantation: temporal accuracy of diagnosis with duplex US and the syndrome of impending thrombosis. Radiology (1996) 1.53
Prevention of cytomegalovirus disease in transplant recipients. Lancet (1995) 1.52
Chronic renal failure following liver transplantation: a retrospective analysis. Transplantation (1998) 1.49
Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology (1998) 1.48
Side-to-side cavo-cavostomy: a useful aid in "complicated" piggy-back liver transplantation. Transpl Int (1993) 1.48
Successful living-related partial liver transplantation to an adult patient. Lancet (1994) 1.47
Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg (1995) 1.45
Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology (2000) 1.44
Primary hepatic malignancy: the role of liver transplantation. Br J Surg (1990) 1.34
A new method of segmental orthotopic liver transplantation in children. Surgery (1988) 1.34
Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients. Lancet (1995) 1.24
Quality of life after liver transplantation for alcoholic liver disease. Liver Transpl (2000) 1.21
Impact of innovative techniques on the waiting list and results in pediatric liver transplantation. Transplantation (1993) 1.20
Sirolimus-tacrolimus combination immunosuppression. Lancet (2000) 1.18
Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group. Hepatology (1999) 1.17
Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation. Drugs (2000) 1.15
A new technique of side to side caval anastomosis during orthotopic hepatic transplantation without inferior vena caval occlusion. Surg Gynecol Obstet (1992) 1.14
In situ splitting of the cadaveric liver for transplantation. Transplantation (1997) 1.14
Successful liver transplantation in babies under 1 year. BMJ (1993) 1.14
The use of mycophenolate mofetil in transplant recipients. Immunopharmacology (2000) 1.13
Alcoholic liver disease. Postgrad Med J (2000) 1.13
Thromboelastography as an indicator of post-cardiopulmonary bypass coagulopathies. J Clin Monit (1987) 1.12
Risk factors for acute renal failure requiring dialysis after liver transplantation. Clin Transplant (1998) 1.11
Mycophenolate mofetil in combination with tacrolimus versus Neoral after liver transplantation. Transplant Proc (1999) 1.09
Selection of the living liver donor. Transplantation (1995) 1.07
Steatosis in donor and transplant liver biopsies. Hum Pathol (2000) 1.06
Correlation between hepatitis C virus prevalence and hepatocellular carcinoma mortality in Europe. J Viral Hepat (1999) 1.06
Review article: mechanisms and management of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxications. Aliment Pharmacol Ther (1999) 1.06
Problematic vascular reconstruction in liver transplantation. Part II. Portovenous conduits. Surgery (1990) 1.04
Diagnosis and management of Crigler-Najjar syndrome. Eur J Pediatr (1999) 1.04
Endoscopic management of biliary strictures in liver transplant recipients: effect on patient and graft survival. Gastrointest Endosc (1998) 1.04
Epithelioid haemangioendothelioma. A case report. J Hepatol (1986) 1.01
In vitro immunosuppressive effects of mycophenolic acid and an ester pro-drug, RS-61443. Transplant Proc (1991) 1.00
Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients. Liver Transpl (2000) 1.00
Split-liver transplantation: a comparison of ex vivo and in situ techniques. J Pediatr Surg (2000) 1.00
Interrelationships of alcohol and iron in liver disease with particular reference to the iron-binding proteins, ferritin and transferrin. J Gastroenterol Hepatol (1999) 1.00
Efficacy of lamivudine in controlling hepatitis B virus recurrence after liver transplantation. Transplantation (1998) 1.00
Living donor liver transplantation for fulminant hepatic failure. Transplantation (2000) 0.99
Policies in Europe on "marginal quality" donor livers. Lancet (1994) 0.98
A prospective randomised trial of bile duct reconstruction at liver transplantation: T tube or no T tube? Transpl Int (1996) 0.98
Vanishing bile-duct syndrome following liver transplantation--is it reversible? Transplantation (1991) 0.98
Histological diagnosis of cytomegalovirus hepatitis in liver allografts. J Clin Pathol (1995) 0.98
Prospective randomized trial of end-to-end versus side-to-side biliary reconstruction after orthotopic liver transplantation. Br J Surg (1999) 0.97
Biliary anastomosis after liver transplantation does not benefit from T tube splintage. Transplantation (1994) 0.96
Living related-donor liver transplantation from adult to adult for primary biliary cirrhosis. Ann Intern Med (1995) 0.96
Successful living related liver transplantation in an adult with fulminant hepatic failure. Transplantation (1997) 0.96
Hepatic artery angioplasty after liver transplantation: experience in 21 allografts. J Vasc Interv Radiol (1995) 0.95
Liver transplantation with monosegments. Surgery (1999) 0.95
Raised hematocrit--a contributing factor to hepatic artery thrombosis following liver transplantation. Transplantation (1988) 0.94
Guidelines for donor selection and an overview of the donor operation in living related liver transplantation. Transpl Int (1996) 0.93
Transplantation for liver and biliary cancer. Semin Surg Oncol (2000) 0.92
Initial response to portoenterostomy determines long-term outcome in patients with biliary atresia. J Pediatr Surg (2000) 0.91
Risk factors for postoperative acute renal failure at a new orthotopic liver transplantation program. Transplant Proc (1999) 0.91
Selective revascularization of hepatic artery thromboses after liver transplantation improves patient and graft survival. Transplantation (1997) 0.90
Hepatic artery thrombosis in infants. A comparison of whole livers, reduced-size grafts, and grafts from living-related donors. Transplantation (1992) 0.90
Incidence, timing, and risk factors for acute and chronic rejection. Liver Transpl Surg (1999) 0.90
Nonoperative management of bile leaks following liver transplantation. Clin Transplant (2000) 0.89
Mucosa-associated lymphoid tissue-type lymphomas occurring in post-transplantation patients. Am J Surg Pathol (2000) 0.89
Results of choledochojejunostomy in the treatment of biliary complications after liver transplantation in the era of nonsurgical therapies. Liver Transpl (2000) 0.89
Liver transplantation for fulminant hepatic failure. Gastroenterol Clin North Am (1993) 0.88
The safety and efficacy of a two-dose daclizumab (zenapax) induction therapy in liver transplant recipients. Transplantation (2000) 0.88
Infection rates with and without T-tube splintage of common bile duct anastomosis in liver transplantation. Transpl Int (1998) 0.88
Donor selection limits use of living-related liver transplantation. Hepatology (1995) 0.88
Prediction of short-term survival with an application in primary biliary cirrhosis. Stat Med (1992) 0.88
Biliary reconstruction without T tubes or stents in liver transplantation: report of 502 consecutive cases. Liver Transpl Surg (1997) 0.87
Biliary complications after paediatric liver transplantation: Birmingham's experience. Transpl Int (1995) 0.87
Living related liver transplantation. Surg Today (1992) 0.87
An approach to the rational use of steatotic donor livers in liver transplantation. Hepatogastroenterology (1999) 0.86
Indications for and timing of liver transplantation. Med Clin North Am (1996) 0.86
The role of imaging in the diagnosis and management of biliary complications after liver transplantation. AJR Am J Roentgenol (1999) 0.86
Assessment of potential donors for living related liver transplantation. Br J Surg (1999) 0.86
Urgent revascularization of liver allografts after early hepatic artery thrombosis. Transplantation (1996) 0.86
Encouraging results of split-liver transplantation. Br J Surg (1998) 0.85
Liver transplantation for fulminant hepatic failure in the United States: October 1987 through December 1991. Clin Transplant (1994) 0.85
FK506 in solid organ transplantation. Ther Drug Monit (1995) 0.85
Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation (2000) 2.90
Marimastat as first-line therapy for patients with unresectable pancreatic cancer: a randomized trial. J Clin Oncol (2001) 2.39
Selective decontamination of the digestive tract reduces gram-negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation. Crit Care Med (1994) 2.21
Bile duct injury following laparoscopic cholecystectomy: referral pattern and management. Br J Surg (1997) 1.81
Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting. Gut (1999) 1.80
Neurological complications following liver transplantation. Lancet (1987) 1.76
Hydatid liver disease as a cause of recurrent pancreatitis. J R Coll Surg Edinb (1999) 1.49
Primary hepatic malignancy: the role of liver transplantation. Br J Surg (1990) 1.34
Orthotopic liver transplantation for alcoholic liver disease: a retrospective analysis of survival, recidivism, and risk factors predisposing to recidivism. Liver Transpl (2001) 1.24
An unusual case of duodenal obstruction-gangliocytic paraganglioma. J Hepatobiliary Pancreat Surg (2009) 1.21
Sclerosing cholangitis associated with multifocal fibrosis: a case report. Gut (1992) 1.17
Patterns of alcohol consumption after liver transplantation. Gut (1998) 1.15
Successful liver transplantation in babies under 1 year. BMJ (1993) 1.14
Significance of positive bacterial cultures from aortic aneurysm contents. Br J Surg (1985) 1.11
Serious paracetamol poisoning and the results of liver transplantation. Gut (1994) 1.10
Outcome of liver resection and transplantation for fibrolamellar hepatocellular carcinoma. Transpl Int (2000) 1.10
Use of grafts procured from organ transplant recipients. Transplantation (1999) 1.06
Liver transplantation for polycystic liver disease. Liver Transpl (2001) 1.06
The use of liver grafts from donors with bacterial meningitis. Transplantation (2001) 1.03
Steroid withdrawal from long-term immunosuppression in liver allograft recipients. Transplantation (1993) 1.02
Policies in Europe on "marginal quality" donor livers. Lancet (1994) 0.98
Vanishing bile-duct syndrome following liver transplantation--is it reversible? Transplantation (1991) 0.98
Increased incidence of chronic rejection in adult patients transplanted for autoimmune hepatitis: assessment of risk factors. Transplantation (2000) 0.98
Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation. J Hepatol (1993) 0.97
Outcome of surgery for chronic pancreatitis. Br J Surg (1997) 0.96
'Fragile' liver and massive hepatic haemorrhage due to hereditary amyloidosis. Gut (1996) 0.94
Raised hematocrit--a contributing factor to hepatic artery thrombosis following liver transplantation. Transplantation (1988) 0.94
Referral of patients with primary biliary cirrhosis for liver transplantation. Gut (1990) 0.94
Successful cadaveric renal transplantation from a donor who died of cyanide poisoning. Br Med J (Clin Res Ed) (1987) 0.90
Controlled trial of low versus high dose oral steroid therapy in 100 cadaveric renal transplants. Proc Eur Dial Transplant Assoc (1981) 0.90
Orthotopic liver transplantation: postoperative complications and their management. Br J Surg (1987) 0.89
Type of donor aortic preservation solution and not cold ischemia time is a major determinant of biliary strictures after liver transplantation. Liver Transpl (2001) 0.89
Clinical features and prognosis of children assessed for isolated small bowel or combined small bowel and liver transplantation. J Pediatr Surg (1997) 0.88
Reversible vanishing bile duct syndrome after liver transplantation: report of 6 cases. Transplant Proc (1991) 0.87
Neuropathological findings in autopsies after liver transplantation. Transplant Proc (1991) 0.87
Inflammatory bowel disease in primary sclerosing cholangitis: an analysis of patients undergoing liver transplantation. Br J Surg (1995) 0.87
Biliary complications after paediatric liver transplantation: Birmingham's experience. Transpl Int (1995) 0.87
Cholangiocarcinoma complicating primary sclerosing cholangitis: a 24-year experience. Dig Surg (2008) 0.86
Factors influencing blood transfusion during adult liver transplantation. Ann R Coll Surg Engl (1993) 0.86
Role of endoscopic retrograde cholangiopancreatography after orthotopic liver transplantation. Gut (1991) 0.86
Long-term nutritional and neurodevelopmental outcome of liver transplantation in infants aged less than 12 months. J Pediatr Gastroenterol Nutr (2000) 0.86
Outcome of liver retransplantation in children. Liver Transpl Surg (1999) 0.85
Development of indications and results during 10 years of orthotopic liver transplantation. Clin Transpl (1993) 0.85
Encouraging results of split-liver transplantation. Br J Surg (1998) 0.85
Donation after cardiac death liver transplant recipients have an increased frequency of acute kidney injury. Am J Transplant (2012) 0.84
Gallbladder conduit vs end-to-end anastomosis of the common bile duct in orthotopic liver transplantation. Transplant Proc (1990) 0.84
Delayed hepatic artery thrombosis in adult orthotopic liver transplantation-a 12-year experience. Transplantation (2001) 0.83
Is elimination of cyclosporine in bile dependent on liver graft function and biliary drainage? Transplant Proc (1988) 0.83
[Primary angiosarcoma of the liver]. Minerva Chir (1997) 0.83
Orthotopic liver transplantation for unresectable hepatoblastoma: a single center's experience. J Pediatr Surg (1999) 0.83
Peripheral neurotoxicity with tacrolimus. Lancet (1994) 0.82
Donor HLA-C genotype has a profound impact on the clinical outcome following liver transplantation. Am J Transplant (2008) 0.82
Reduced acute rejection after liver transplantation with Neoral-based triple immunosuppression. Lancet (1997) 0.82
Effect on outcome of the lengthening waiting list for liver transplantation. Gut (2000) 0.82
Primary hepatocellular cancer in the explanted liver: outcome of transplantation and risk factors for HCC recurrence. Eur J Surg Oncol (2007) 0.81
Massive haemorrhagic necrosis of the liver after liver transplantation. J Clin Pathol (1989) 0.81
HLA matching in liver transplantation: a retrospective analysis. Transplant Proc (1992) 0.81
Quantitation of cytomegalovirus in the blood of liver transplant recipients. Liver Transpl Surg (1995) 0.81
Reduced incidence of rejection in patients undergoing liver transplantation for chronic hepatitis B. Transplant Proc (1991) 0.81
Impact of donor liver microvesicular steatosis on the outcome of liver retransplantation. Transplant Proc (1999) 0.81
The future of small bowel transplantation. Arch Dis Child (1995) 0.81
Analysis of marginal donor parameters in liver transplantation for primary biliary cirrhosis. Exp Clin Transplant (2004) 0.80
Metabolic and hormonal effects of tacrolimus (FK506) or cyclosporin immunosuppression following renal transplantation. Diabetes Obes Metab (2001) 0.80
Pretransplant prediction of prognosis after liver transplantation in primary sclerosing cholangitis using a Cox regression model. Hepatology (1999) 0.80
Nutritional care and candidates for small bowel transplantation. Arch Dis Child (1995) 0.80
Correction of severe hyponatraemia by continuous arteriovenous haemofiltration before liver transplantation. BMJ (1988) 0.80
Heparin therapy and bone fractures. Lancet (1992) 0.80
Can effluent hyaluronic acid or creatine kinase predict sinusoidal injury severity after cold ischemia? Transplantation (1993) 0.79
Influence of ischemia-reperfusion injury on rejection after liver transplantation. Transplant Proc (1997) 0.79
Haematological malignancies presenting with acute liver injury: a single-centre experience. QJM (2008) 0.79
Hepatic transplantation in children using reduced size allografts. Br J Surg (1992) 0.79
Acute liver allograft rejection--is treatment always necessary? Transplantation (1993) 0.79
Obstructive jaundice associated with polycystic liver disease. HPB Surg (1996) 0.79
Orthotopic liver transplantation for hepatic GVHD following allogeneic BMT for chronic myeloid leukaemia. Bone Marrow Transplant (1992) 0.79
Bile duct splintage in liver transplantation: is it necessary? Transpl Int (1996) 0.79
Energy storage and cytokine response in patients undergoing liver transplantation. Cytokine (1999) 0.79
Progress in pediatric liver transplantation--the Birmingham experience. J Pediatr Surg (1997) 0.79
Risk factors for liver rejection: evidence to suggest enhanced allograft tolerance in infancy. Arch Dis Child (1996) 0.79
Optimal timing of liver transplantation for patients with primary biliary cirrhosis: use of prognostic modelling. J Hepatol (1999) 0.78
The role of dynamic and morphological studies in the assessment of potential liver donors. Transplantation (1994) 0.78
Repeat orthotopic liver transplantation in the 1990s: is it justified? Transpl Int (1998) 0.78
Postperfusion energy metabolism of steatotic graft and its relation to early graft viability following liver transplantation. Dig Dis Sci (1998) 0.77
Ten-year results of a randomised prospective study of FK506 versus cyclosporine in management of primary orthotopic liver transplantation. Transplant Proc (2002) 0.77
Long-term immunosuppression after liver transplantation: are steroids necessary? Transpl Int (1992) 0.77
Factors predicting perioperative cytokine response in patients undergoing liver transplantation. Crit Care Med (2000) 0.77
Restorative proctocolectomy and pouch anal anastomosis for ulcerative colitis following orthotopic liver transplantation. Gut (1995) 0.77
Influence of intraoperative blood loss on plasma levels of cytokines and endotoxin and subsequent graft liver function. Arch Surg (1997) 0.77
Color flow Doppler ultrasound diagnosis of a pseudoaneurysm of the hepatic artery following liver transplantation. J Clin Ultrasound (1994) 0.77
Perihepatic packing in liver transplantation. Transplant Proc (1998) 0.77
Fluconazole prophylaxis for high-risk liver transplant recipients. Lancet (1995) 0.77
Changing referral pattern of biliary injuries sustained during laparoscopic cholecystectomy. Br J Surg (2000) 0.77
Early experience of paediatric intestinal transplantation in the United Kingdom, 1993 to 1999. Transplant Proc (2000) 0.77
Demand for pediatric small bowel transplantation in the United Kingdom. Transplant Proc (1998) 0.76
Is selective decontamination of the digestive tract beneficial in liver transplant patients? Interim results of a prospective, randomized trial. Transplant Proc (1991) 0.76
Is chronic rejection of liver transplants different from graft arteriosclerosis of kidney and heart transplants? Transplant Proc (1997) 0.76
Extended preservation of the liver with UW solution--is it justifiable? Transplantation (1994) 0.76
Role of total hepatectomy and transplantation in hepatocellular carcinoma. Transplant Proc (1994) 0.76
Biliary reconstruction with or without an internal biliary stent in orthotopic liver transplantation: a prospective randomised trial. Transpl Int (1998) 0.76
Outcome of graft function and pregnancy following liver transplantation. Transplant Proc (1997) 0.76